AI Price Corridor Modeling: Stop Leaving Money on the Table at Launch
The MFN executive order and IRA have made pharma pricing a dynamic multi-market corridor management challenge. AI price corridor models continuously track IRP linkages, HTA outcomes, and launch sequence implications across markets. This article explains how biotech market access teams can build AI corridor modeling capability using publicly available data.
AI Price Corridor Modeling: Stop Leaving Money on the Table at Launch Read More »